Trademark: 97441083
Status Date
Tuesday, April 9, 2024
Filing Date
Thursday, June 2, 2022
Published for Opposition
Tuesday, July 25, 2023
44 Medical diagnostic testing, monitoring and reporting services for the detection of cancer using blood samples; medical screening and diagnostic services for the diagnosis of cancer, namely, providing testing services to detect the presence of cancer in an individual based on the analysis of blood samples using artificial intelligence and the detection of cfDNA methylation markers; all of the aforementioned services are performed using liquid biopsy cancer screenings
Apr 9, 2024
Noa E-Mailed - Sou Required From Applicant
Feb 21, 2024
Ttab Release Case To Trademarks
Feb 21, 2024
Opposition Terminated No. 999999
Feb 21, 2024
Opposition Dismissed No. 999999
Nov 8, 2023
Opposition Instituted No. 999999
Aug 23, 2023
Extension Of Time To Oppose Received
Jul 25, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2023
Published For Opposition
Jul 5, 2023
Notification Of Notice Of Publication E-Mailed
Jun 20, 2023
Approved For Pub - Principal Register
Jun 17, 2023
Teas/Email Correspondence Entered
Jun 16, 2023
Correspondence Received In Law Office
Jun 16, 2023
Teas Response To Office Action Received
Mar 19, 2023
Notification Of Non-Final Action E-Mailed
Mar 19, 2023
Non-Final Action E-Mailed
Mar 19, 2023
Non-Final Action Written
Mar 18, 2023
Assigned To Examiner
Jun 13, 2022
New Application Office Supplied Data Entered
Jun 6, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
